| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.43B | -0.1% |
| Cost of Revenue | $7.31B | -3.9% |
| R&D Expense | $16.0M | +14.3% |
| SG&A Expense | $805.0M | +4.0% |
| Operating Income | $1.17B | +29.6% |
| Interest Expense | $239.0M | +21.3% |
| Pre-tax Income | $932.0M | +30.2% |
| Income Tax | $210.0M | +8.2% |
| Net Income | $723.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $162.0M | +8.0% |
| Accounts Receivable | $716.0M | -10.9% |
| Inventory | $1.75B | +9.2% |
| Current Assets | $2.85B | +5.1% |
| Total Assets | $11.18B | +8.2% |
| Current Liabilities | $2.59B | +33.9% |
| Long-term Debt | $5.22B | +2.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.14B | +5.0% |
| Investing Cash Flow | -$1.02B | -135.6% |
| Financing Cash Flow | -$106.0M | +84.1% |
| +38.5% |
| EPS (Basic) | $2.35 | +39.1% |
| EPS (Diluted) | $2.34 | +38.5% |
| Stockholders' Equity |
| $2.78B |
| +29.4% |